查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750886

球體市場規模、佔有率、趨勢分析報告：按類型、方法、來源、應用、最終用途、地區、細分市場預測，2025-2030 年

Spheroids Market Size, Share & Trends Analysis Report By Type, By Method, By Source, By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine), By End Use, By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

球體市場的成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球球狀體市場規模預計到 2030 年將達到 24.6 億美元，2025 年至 2030 年的複合年成長率為 22.7%。

由於對先進的3D細胞培養模型的需求日益成長，該市場正獲得顯著發展，因為這種模型比傳統的2D培養提供了更符合生理學的條件。球狀體能夠更好地模擬細胞結構、營養梯度和體內組織微環境，並在藥物篩檢、疾病建模、毒性測試和再生醫學領域中得到越來越廣泛的應用。它們的應用涵蓋了廣泛的治療領域，包括腫瘤學、神經病學和代謝疾病，因為研發和製藥公司優先考慮更精確的臨床前模型，以提高藥物開發的成功率並減少後期失敗。

另一個主要促進因素是將球體納入高通量篩檢(HTS) 系統，這使得製藥和生物技術公司能夠評估具有更高預測值的大型化合物庫。低黏附板、懸滴系統和微流體平台等新工具和技術的開發也推動了市場的發展，這些技術簡化了球體的生產並提高了可重複性。此外，政府機構和私人投資者的資金投入不斷增加，也支持了 3D 培養研究在學術和商業性領域的擴展。

COVID-19 疫情進一步加速了細胞球模型的應用，尤其是在病毒學和免疫學研究中。隨著研究人員尋求更接近人體組織的模型，細胞球已被證明在研究 SARS-CoV-2 感染機制、宿主免疫反應和抗病毒藥物療效方面大有裨益。疫情凸顯了傳統2D培養和動物模型在快速理解複雜疾病方面的局限性，促使人們增加了對包括細胞球在內的 3D 培養技術的投資。這種轉變也支持了市場的長期成長，因為實驗室紛紛採用先進的培養系統來鞏固其未來的研究基礎。

即使疫情過後，由於全球都在努力推行更符合倫理、更有效率的臨床前測試策略，球狀體市場仍保持強勁成長動能。監管機構和研究機構越來越認知到球狀體和其他3D模型在減少動物試驗和提升轉化效果的價值。此外，個人化醫療的興起以及利用患者來源細胞製備針對特異性疾病的球狀體，為定製藥物開發和治療測試開闢了新的機會。這些因素共同推動了球狀體市場在未來幾年的強勁成長。

球體市場報告重點

  • 多細胞腫瘤球體 (MCTS) 細分市場預計將在 2024 年佔據最大的收益佔有率，達到 28.91%，並有望在預測期內以最快的速度成長。 MCTS 能夠忠實地再現體內腫瘤微環境，從而實現更精準的癌症研究和藥物篩檢。其模擬腫瘤異質性和抗藥性的能力正推動其在腫瘤學研究中的應用。
  • 吊掛滴技術預計將在2024年佔據最大的收益佔有率，達到31.34%，並有望在預測期內實現最快的成長率。這項簡單且經濟高效的技術無需支架即可形成均勻的球體，使其成為可控實驗裝置的理想選擇。其易用性以及與高通量系統的兼容性使其在研究中廣泛應用。
  • 細胞株係部分在 2024 年佔據了 56.64% 的顯著收益佔有率。細胞株係是主要的市場驅動力，因為它們提供了標準化、可重複且經濟高效的資源，可用於產生廣泛研究應用的 3D 球體模型。
  • 再生醫學領域預計將在預測期內實現最高的複合年成長率。球狀體透過促進細胞間相互作用和模擬天然組織結構來增強組織工程。球狀體在開發功能性組織結構方面的作用在再生療法中至關重要。
  • 2024年，生物技術和製藥產業佔了最大的收益佔有率，達到46.33%。這些行業利用球體進行預測毒理學、療效篩檢和疾病建模。對可擴展、與人體相關的3D模型的需求正在推動其融入開發平臺。
  • 北美憑藉其完善的法律規範和醫療保健基礎設施佔據市場主導地位，這有助於基於球體的產品的臨床應用和採用，進一步推動市場成長。
  • 賽默飛世爾科技公司、康寧公司、默克公司、龍沙公司、InSphero AG、Greiner Bio-One International GmbH、3D Biotek LLC、CN Bio Innovations、可樂麗公司。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 球體市場變數與趨勢

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 球體市場分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 業務類型分析

  • 細分儀表板
  • 全球球體市場：類型變異分析
  • 全球球體市場規模及趨勢分析（按類型，2018-2030）
  • 多細胞腫瘤球體（MCTS）
  • 神經球
  • 乳球體
  • 肝球
  • 胚胎樣狀體

第5章 依方法論進行的商業分析

  • 細分儀表板
  • 全球球體市場：方法論變異分析
  • 全球球體市場規模及趨勢分析（依方法，2018-2030）
  • 微圖案板
  • 低細胞附著板
  • 懸滴法
  • 其他

第6章 供應源業務分析

  • 細分儀表板
  • 全球球狀體市場：來源變異分析
  • 全球球體市場規模與趨勢分析（按來源）（2018-2030 年）
  • 細胞株
  • 初代細胞
  • iPSC衍生細胞

第7章 按最終用途分類的業務分析

  • 細分儀表板
  • 全球球體市場：最終用途差異分析
  • 全球球體市場規模與趨勢分析（依最終用途，2018-2030 年）
  • 生物技術和製藥業
  • 學術研究所
  • 醫院和診斷中心

第 8 章 按應用程式進行業務分析

  • 細分儀表板
  • 全球球體市場：應用趨勢分析
  • 全球球體市場規模及趨勢分析（按應用，2018-2030）
  • 發育生物學
  • 個人化醫療
  • 再生醫學
  • 疾病病理學研究
  • 藥物毒性和療效研究

第9章區域業務分析（按國家、按類型、按方法、按來源、按應用和按最終用途）

  • 細分儀表板
  • 2018年至2030年市場規模、預測與趨勢分析
  • 北美洲
    • 2018-2030年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太市場估計與預測
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年MEA市場預測及預測
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司分類
  • 戰略地圖
  • 2024年企業地位分析
  • 公司簡介/列表
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Lonza
    • CN Bio Innovations
    • 3D Biotek LLC
    • Kuraray Co., Ltd.
    • Tecan Group Ltd.
    • Corning Incorporated
    • Greiner Bio-One
    • InSphero
Product Code: GVR-4-68040-562-8

Spheroids Market Growth & Trends:

The global spheroids market size is expected to reach USD 2.46 billion by 2030 and is anticipated to grow at a CAGR of 22.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has gained significant traction due to the growing demand for advanced 3D cell culture models that offer more physiologically relevant conditions than traditional 2D cultures. Spheroids, which better mimic the cellular architecture, nutrient gradients, and microenvironment of tissues in vivo, are increasingly used in drug screening, disease modeling, toxicology testing, and regenerative medicine. Their application spans a wide range of therapeutic areas, including oncology, neurology, and metabolic diseases, as researchers and pharmaceutical companies prioritize more accurate preclinical models to improve drug development success rates and reduce late-stage failures.

Another major driver is the integration of spheroids into high-throughput screening (HTS) systems, enabling pharmaceutical and biotechnology companies to evaluate large compound libraries with greater predictive value. The market is also fueled by developing novel tools and technologies such as low-attachment plates, hanging drop systems, and microfluidic platforms that simplify spheroid generation and improve reproducibility. In addition, increased funding from government agencies and private investors has supported the expansion of 3D culture research in academic and commercial settings.

The COVID-19 pandemic further accelerated the adoption of spheroid models, particularly in virology and immunology research. As researchers sought models that more closely represented human tissues, spheroids proved valuable for studying SARS-CoV-2 infection mechanisms, host immune responses, and antiviral drug efficacy. The pandemic highlighted the limitations of conventional 2D cultures and animal models in rapidly understanding complex diseases, leading to increased investment in 3D culture technologies, including spheroids. This shift also supported long-term market growth as laboratories increasingly adopted advanced culture systems to future-proof research infrastructure.

Post-pandemic, the momentum around spheroids has continued, driven by a global push toward more ethical and efficient preclinical testing strategies. Regulatory agencies and research institutions increasingly recognize the value of spheroids and other 3D models in reducing animal testing while improving translational outcomes. Furthermore, the rise of personalized medicine and the use of patient-derived cells to form disease-specific spheroids are opening new opportunities for customized drug development and therapeutic testing. Together, these factors are shaping a robust outlook for the market in the years ahead.

Spheroids Market Report Highlights:

  • The multicellular tumor spheroids (MCTS) segment accounted for the largest revenue share of 28.91% in 2024 and is expected to have the fastest growth rate over the forecast period. MCTS closely replicates the in vivo tumor microenvironment, enabling more accurate cancer research and drug screening. Their ability to model tumor heterogeneity and drug resistance drives their adoption in oncology-focused studies.
  • The hanging drop method segment accounted for the largest revenue share of 31.34% in 2024 and is expected to have the fastest growth rate over the forecast period. This simple and cost-effective technique facilitates uniform spheroid formation without scaffolds, ideal for controlled experimental setups. Its ease of use and compatibility with high-throughput systems support widespread research adoption.
  • The cell line segment accounted for a larger revenue share of 56.64% in 2024. Cell lines are a major market driver because they provide a standardized, reproducible, and cost-effective resource for generating 3D spheroid models across a wide range of research applications.
  • The regenerative medicine segment is expected to witness the highest CAGR over the forecast period. Spheroids enhance tissue engineering by promoting cell-cell interactions and mimicking native tissue structures. Their role in developing functional tissue constructs makes them essential in regenerative therapies.
  • The biotechnology and pharmaceutical industries segment accounted for the largest revenue share of 46.33% in 2024. These industries utilize spheroids for predictive toxicology, efficacy screening, and disease modeling. The demand for human-relevant, scalable 3D models drives their integration into R&D pipelines.
  • North America dominated the market due to its well-established regulatory frameworks and healthcare infrastructure. These facilitate the clinical translation and adoption of spheroid-based products, further propelling market growth.
  • Thermo Fisher Scientific Inc., Corning Incorporated, Merck KGaA, Lonza, InSphero AG, Greiner Bio-One International GmbH, 3D Biotek LLC, CN Bio Innovations, Kuraray Co., Ltd., and Tecan Group Ltd. are some of the market players operating in the market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Method
    • 1.1.3. Source
    • 1.1.4. Application
    • 1.1.5. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Spheroids Market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High adoption of spheroids in drug discovery
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising demand for tissue engineering & organ transplantation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Challenges associated with 3D cell culturing
      • 3.2.2.2. Ethical issues associated with spheroid cultures
  • 3.3. Spheroids Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Spheroids Market: Type Movement Analysis
  • 4.3. Global Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Multicellular tumor spheroids (MCTS)
    • 4.4.1. MCTS market estimates and forecast, 2018 - 2030
  • 4.5. Neurospheres
    • 4.5.1. Neurospheres market estimates and forecast, 2018 - 2030
  • 4.6. Mammospheres
    • 4.6.1. Mammospheres market estimates and forecast, 2018 - 2030
  • 4.7. Hepatospheres
    • 4.7.1. Hepatospheres market estimates and forecast, 2018 - 2030
  • 4.8. Embryoid bodies
    • 4.8.1. Embryoid bodies market estimates and forecast, 2018 - 2030

Chapter 5. Method Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Spheroids Market: Method Movement Analysis
  • 5.3. Global Spheroids Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 5.4. Micropatterned Plates
    • 5.4.1. Micropatterned plates market estimates and forecast, 2018 - 2030
  • 5.5. Low Cell Attachment Plates
    • 5.5.1. Low cell attachment plates market estimates and forecast, 2018 - 2030
  • 5.6. Hanging Drop Method
    • 5.6.1. Hanging drop method market estimates and forecast, 2018 - 2030
  • 5.7. Others
    • 5.7.1. Other methods market estimates and forecast, 2018 - 2030

Chapter 6. Source Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Spheroids Market: Source Movement Analysis
  • 6.3. Global Spheroids Market Size & Trend Analysis, by Source, 2018 to 2030 (USD Million)
  • 6.4. Cell Line
    • 6.4.1. Cell line market estimates and forecast, 2018 - 2030
  • 6.5. Primary Cell
    • 6.5.1. Primary cell market estimates and forecast, 2018 - 2030
  • 6.6. iPSCs Derived Cells
    • 6.6.1. iPSCs derived cells market estimates and forecast, 2018 - 2030

Chapter 7. End Use Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Spheroids Market: End Use Movement Analysis
  • 7.3. Global Spheroids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Biotechnology and Pharmaceutical Industries
    • 7.4.1. Biotechnology and pharmaceutical industries market estimates and forecast 2018 to 2030, (USD million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & research institutes market estimates and forecast 2018 to 2030, (USD Million)
  • 7.6. Hospitals and Diagnostic Centers
    • 7.6.1. Hospitals and diagnostic centers market estimates and forecast 2018 to 2030, (USD million)

Chapter 8. Application Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Spheroids Market: Application Movement Analysis
  • 8.3. Global Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 8.4. Developmental Biology
    • 8.4.1. Developmental biology market estimates and forecast 2018 to 2030, (USD million)
  • 8.5. Personalized Medicine
    • 8.5.1. Personalized medicine market estimates and forecast 2018 to 2030, (USD Million)
  • 8.6. Regenerative Medicine
    • 8.6.1. Regenerative medicine market estimates and forecast 2018 to 2030, (USD million)
  • 8.7. Disease Pathology Studies
    • 8.7.1. Disease pathology studies market estimates and forecast 2018 to 2030, (USD Million)
  • 8.8. Drug Toxicity & Efficacy Testing
    • 8.8.1. Drug toxicity & efficacy testing market estimates and forecast 2018 to 2030, (USD Million)

Chapter 9. Regional Business Analysis, by Country, Type, Method, Source, Application, & End Use

  • 9.1. Segment Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. U.S. Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Canada Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Mexico Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4. Europe
    • 9.4.1. Europe Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. UK Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Germany Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. France Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Italy Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Spain Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Denmark Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Sweden Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Target Disease Prevalence
      • 9.4.9.3. Competitive Scenario
      • 9.4.9.4. Norway Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.2. China
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. China Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.3. Japan
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. India Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Australia Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Target Disease Prevalence
      • 9.5.6.3. Competitive Scenario
      • 9.5.6.4. Thailand Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Target Disease Prevalence
      • 9.5.7.3. Competitive Scenario
      • 9.5.7.4. South Korea Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.6. Latin America
    • 9.6.1. Latin America Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Brazil Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Argentina Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.7. MEA
    • 9.7.1. MEA Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Target Disease Prevalence
      • 9.7.2.3. Competitive Scenario
      • 9.7.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.7.3. South Africa
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Target Disease Prevalence
      • 9.7.3.3. Competitive Scenario
      • 9.7.3.4. South Africa Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Target Disease Prevalence
      • 9.7.4.3. Competitive Scenario
      • 9.7.4.4. UAE Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Target Disease Prevalence
      • 9.7.5.3. Competitive Scenario
      • 9.7.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Thermo Fisher Scientific, Inc.
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Merck KGaA
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Lonza
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. CN Bio Innovations
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. 3D Biotek LLC
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Kuraray Co., Ltd.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Tecan Group Ltd.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Corning Incorporated
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Greiner Bio-One
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. InSphero
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 4 North America spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 5 North America spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 North America spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 8 U.S. spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 10 U.S. spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 11 U.S. spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 15 Canada spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 16 Canada spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 19 Mexico spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 20 Mexico spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 21 Mexico spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Mexico spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 24 Europe spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 25 Europe spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 26 Europe spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Europe spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 29 Germany spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 30 Germany spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 31 Germany spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 32 Germany spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Germany spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 34 UK spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 35 UK spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 36 UK spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 37 UK spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 UK spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 39 France spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 40 France spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 41 France spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 42 France spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 43 France spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 45 Italy spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 46 Italy spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 47 Italy spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Italy spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 49 Spain spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 50 Spain spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 51 Spain spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 52 Spain spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Spain spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 54 Sweden spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 55 Sweden spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 56 Sweden spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 57 Sweden spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Sweden spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 59 Norway spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 60 Norway spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 61 Norway spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 62 Norway spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Norway spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 65 Denmark spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 66 Denmark spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 67 Denmark spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 68 Denmark spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 69 APAC spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 70 APAC spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 71 APAC spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 72 APAC spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 73 APAC spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 74 APAC spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 75 China spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 76 China spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 77 China spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 78 China spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 China spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 80 Japan spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 81 Japan spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 82 Japan spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 83 Japan spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 Japan spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 85 India spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 86 India spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 87 India spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 88 India spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 89 India spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 90 Thailand spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 91 Thailand spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 92 Thailand spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 93 Thailand spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 94 Thailand spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 95 South Korea spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 96 South Korea spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 97 South Korea spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 98 South Korea spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 99 South Korea spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 100 Australia spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 101 Australia spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 102 Australia spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 103 Australia spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 104 Australia spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 105 Latin America spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 106 Latin America spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 107 Latin America spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 108 Latin America spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 109 Latin America spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 110 Latin America spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 111 Brazil spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 112 Brazil spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 113 Brazil spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 114 Brazil spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 115 Brazil spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 116 Argentina spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 117 Argentina spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 118 Argentina spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 119 Argentina spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 120 Argentina spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 121 Middle East and Africa spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 122 Middle East and Africa spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 123 Middle East and Africa spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 124 Middle East and Africa spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 125 Middle East and Africa spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 126 Middle East and Africa spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 127 South Africa spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 128 South Africa spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 129 South Africa spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 130 South Africa spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 131 South Africa spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 137 UAE spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 138 UAE spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 139 UAE spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 140 UAE spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 141 UAE spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 142 Kuwait spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 143 Kuwait spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 144 Kuwait spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 145 Kuwait spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 146 Kuwait spheroids market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Spheroids: market outlook
  • Fig. 9 Spheroids competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Spheroids market driver impact
  • Fig. 13 Spheroids market restraint impact
  • Fig. 14 Spheroids market strategic initiatives analysis
  • Fig. 15 Spheroids market: type movement analysis
  • Fig. 16 Spheroids market: type outlook and key takeaways
  • Fig. 17 MCTS market estimates and forecast, 2018 - 2030
  • Fig. 18 Neurospheres market estimates and forecast, 2018 - 2030
  • Fig. 19 Mammospheres market estimates and forecast, 2018 - 2030
  • Fig. 20 Hepatospheres market estimates and forecast, 2018 - 2030
  • Fig. 21 Embryoid bodies market estimates and forecast, 2018 - 2030
  • Fig. 22 Spheroids market: method movement analysis
  • Fig. 23 Spheroids market: method outlook and key takeaways
  • Fig. 24 Micropatterned plates market estimates and forecast, 2018 - 2030
  • Fig. 25 Low cell attachment plates market estimates and forecast, 2018 - 2030
  • Fig. 26 Hanging drop method for spheroid culture market estimates and forecast, 2018 - 2030
  • Fig. 27 Other methods for spheroid culture market estimates and forecast, 2018 - 2030
  • Fig. 28 Spheroids market: source movement analysis
  • Fig. 29 Spheroids market: source outlook and key takeaways
  • Fig. 30 Cell line market estimates and forecast, 2018 - 2030
  • Fig. 31 Primary cell market estimates and forecast, 2018 - 2030
  • Fig. 32 iPSCs derived cells market estimates and forecast, 2018 - 2030
  • Fig. 33 Spheroids market: End Use movement analysis
  • Fig. 34 Spheroids market: End Use outlook and key takeaways
  • Fig. 35 Biotechnology and pharmaceutical industries market estimates and forecast, 2018- 2030
  • Fig. 36 Academic & research institutes market estimates and forecast, 2018 - 2030
  • Fig. 37 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030
  • Fig. 38 Spheroids market: application movement analysis
  • Fig. 39 Spheroids market: application outlook and key takeaways
  • Fig. 40 Developmental biology market estimates and forecast, 2018 - 2030
  • Fig. 41 Personalized medicine market estimates and forecast, 2018 - 2030
  • Fig. 42 Regenerative medicine market estimates and forecast, 2018 - 2030
  • Fig. 43 Disease pathology studies market estimates and forecast, 2018 - 2030
  • Fig. 44 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030
  • Fig. 45 Global Spheroids market: regional movement analysis
  • Fig. 46 Global Spheroids market: regional outlook and key takeaways
  • Fig. 47 North America
  • Fig. 48 North America market estimates and forecast, 2018 - 2030
  • Fig. 49 U.S. key country dynamics
  • Fig. 50 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 51 Canada key country dynamics
  • Fig. 52 Canada market estimates and forecast, 2018 - 2030
  • Fig. 53 Mexico key country dynamics
  • Fig. 54 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 55 Europe
  • Fig. 56 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 57 UK key country dynamics
  • Fig. 58 UK market estimates and forecast, 2018 - 2030
  • Fig. 59 Germany key country dynamics
  • Fig. 60 Germany market estimates and forecast, 2018 - 2030
  • Fig. 61 France key country dynamics
  • Fig. 62 France market estimates and forecast, 2018 - 2030
  • Fig. 63 Italy key country dynamics
  • Fig. 64 Italy market estimates and forecast, 2018 - 2030
  • Fig. 65 Spain key country dynamics
  • Fig. 66 Spain market estimates and forecast, 2018 - 2030
  • Fig. 67 Sweden key country dynamics
  • Fig. 68 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 69 Norway key country dynamics
  • Fig. 70 Norway market estimates and forecast, 2018 - 2030
  • Fig. 71 Denmark key country dynamics
  • Fig. 72 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 73 Asia Pacific
  • Fig. 74 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 75 China key country dynamics
  • Fig. 76 China market estimates and forecast, 2018 - 2030
  • Fig. 77 Japan key country dynamics
  • Fig. 78 Japan market estimates and forecast, 2018 - 2030
  • Fig. 79 India key country dynamics
  • Fig. 80 India market estimates and forecast, 2018 - 2030
  • Fig. 81 Australia key country dynamics
  • Fig. 82 Australia market estimates and forecast, 2018 - 2030
  • Fig. 83 Thailand key country dynamics
  • Fig. 84 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 85 South Korea key country dynamics
  • Fig. 86 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 87 Latin America
  • Fig. 88 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 89 Brazil key country dynamics
  • Fig. 90 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 91 Argentina key country dynamics
  • Fig. 92 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 93 Middle East and Africa
  • Fig. 94 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 95 Saudi Arabia key country dynamics
  • Fig. 96 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 97 South Africa key country dynamics
  • Fig. 98 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 99 UAE key country dynamics
  • Fig. 100 UAE market estimates and forecast, 2018 - 2030
  • Fig. 101 Kuwait key country dynamics
  • Fig. 102 Kuwait market estimates and forecast, 2018 - 2030